| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |